Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024
10 juin 2024 08h00 HE
|
Autonomix Medical, Inc.
Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) -- – Autonomix Medical, Inc. (NASDAQ: AMIX)...
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
22 févr. 2024 08h00 HE
|
Autonomix Medical, Inc.
Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Company expects to commence patient enrollment imminently...
Sécurisation de l’approvisionnement en plasma du Canada
06 août 2019 13h00 HE
|
Société canadienne du sang
OTTAWA, 06 août 2019 (GLOBE NEWSWIRE) -- La Société canadienne du sang a le plaisir d’annoncer qu’avec le soutien de ses bailleurs de fonds, elle a entrepris d’augmenter la quantité de plasma...
Securing Canada’s plasma supply
06 août 2019 13h00 HE
|
Canadian Blood Services
OTTAWA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Canadian Blood Services is pleased to announce that with the support of funding governments, plans are now underway to increase plasma collection with three...
PROVECTUS BIOPHARMACEUTICALS PROVIDES DRUG DEVELOPMENT UPDATE FOR IMMUNO-DERMATOLOGY ASSET PH-10
14 nov. 2018 07h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s small molecule clinical development program for its investigational...
GrowLife, Inc. Announces 4x Increase in Production Capacity from 15 to 70 Plants Using its Proprietary Vertical Grow Room
18 juil. 2018 09h00 HE
|
GrowLife, Inc.
KIRKLAND, Wash., July 18, 2018 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB:PHOT), one of the nation’s most recognized indoor cultivation product and service providers, today announced preliminary test...